Study #2023-0933
Structured personalized oxygen and supportive therapies for dyspnea in oncology (SPOT-ON) approach for dyspnea treatment in cancer patients: an R01 randomized clinical trial
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Dyspnea
Study phase:
Phase II/III
Physician name:
David Hui
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.